Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mbombe Kazoka
Observed name:
Kazoka, M.
Observed institutions:
King's College London,
Trinity College Dublin,
Royal Hallamshire Hospital,
University Medical Center Utrecht,
Sheffield Children's Hospital,
University of Sheffield,
Macquarie University
show all 7
OpenAlex ID:
A5061606150
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
2018
·
Henk-Jan Westeneng
, Thomas P A Debray
, et al.
·
The Lancet Neurology
·
526
PDF
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
2017
·
Davina J Hensman Moss
, Antonio F Pardiñas
, et al.
·
The Lancet Neurology
·
310
PDF
Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)
2017
·
Rachel Waller
, Emily F. Goodall
, et al.
·
Neurobiology of Aging
·
144
PDF
Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity
2018
·
Rachel Waller
, Matthew Wyles
, et al.
·
Frontiers in Neuroscience
·
99
PDF
Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis
2019
·
Johnathan Cooper-Knock
, Tobias Moll
, et al.
·
Cell Reports
·
81
PDF
Clinical manifestations of intermediate allele carriers in Huntington disease
2016
·
Esther Cubo
, María A. Ramos-Arroyo
, et al.
·
Neurology
·
53
Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis
2026
·
Timothy M. Miller
, Merit E. Cudkowicz
, et al.
·
JAMA Neurology
·
40
PDF
Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study
2018
·
Paul McNulty
, Richard Pilcher
, et al.
·
Journal of Huntington s Disease
·
35
Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype
2017
·
Johnathan Cooper-Knock
, Henry Robins
, et al.
·
Frontiers in Molecular Neuroscience
·
32
PDF
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
2023
·
Flavia L. Lombardo
, Stefania Spila Alegiani
, et al.
·
Trials
·
13
PDF
Meaningful and Measurable Health Domains in Huntington’s Disease: Large-Scale Validation of the Huntington’s Disease Health-Related Quality of Life Questionnaire Across Severity Stages
2019
·
Aileen K. Ho
, Mike C. Horton
, et al.
·
Value in Health
·
9
Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival
2023
·
Rachel Waller
, Joanna J Bury
, et al.
·
Brain Communications
·
4
PDF
Prediction of personalised prognosis in patients with amyotrophic lateral sclerosis: development and validation of a prediction model
2018
·
Henk‐Jan Westeneng
, Debray Tpa.
, et al.
·
The Lancet Neurology
·
3
Mutations in the Glycosyltransferase Domain of GLT8D1 Cause Amyotrophic Lateral Sclerosis
2018
·
Johnathan Cooper-Knock
, Tobias Moll
, et al.
·
SSRN Electronic Journal
·
1
Long-term tofersen in SOD1 amyotrophic lateral sclerosis
2025
·
Miller, T.M.
, Cudkowicz, M.E.
, et al.
·
White Rose Research Online (University of Leeds, The University of Sheffield, University of York)
PDF
Show more works
View as search
Works count:
15
Citation count:
1,350
H-index:
10
I10-index:
10
Year
Topic
Type
